Literature DB >> 21920944

Comparing shingles incidence and complication rates from medical record review and administrative database estimates: how close are they?

Barbara P Yawn1, Peter Wollan, Jennifer St Sauver.   

Abstract

Accurate rates of herpes zoster incidence and complication have become of greater interest as studies have suggested an increasing temporal trend in incidence rates across all age groups and long-term follow-up studies of vaccine effectiveness are required by the Food and Drug Administration. This study compares the results obtained from the most commonly used method to obtain herpes zoster data (rates obtained from administrative data) with results obtained when administrative data are supplemented by medical record review. Administrative billing code data identified 1,959 cases of herpes zoster in Olmsted County, Minnesota, adults between January 1, 1996, and December 31, 2001. Of those 1,959 cases, 1,669 (85.2%) could be confirmed by medical record review, a decrease in incidence rate of 14.8%, resulting in a decrease of 0.61/1,000 person-years when adjusted to the US adult population. Complication rates were also significantly different between the 2 methods. It is not clear if the 15% decrease in incidence rates would be seen in every administrative data set or if the lack of confirmation of cases may be variable in both validity and reproducibility between data sets, making estimations in temporal trends and pre/post-vaccine rates difficult to compare across data resources.

Entities:  

Mesh:

Year:  2011        PMID: 21920944      PMCID: PMC3243933          DOI: 10.1093/aje/kwr206

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  42 in total

1.  The incidence of shingles and its implications for vaccination policy.

Authors:  Rachel S Chapman; Kenneth W Cross; Douglas M Fleming
Journal:  Vaccine       Date:  2003-06-02       Impact factor: 3.641

2.  Interrater reliability: completing the methods description in medical records review studies.

Authors:  Barbara P Yawn; Peter Wollan
Journal:  Am J Epidemiol       Date:  2005-05-15       Impact factor: 4.897

3.  Evaluation of the cost-effectiveness in the United States of a vaccine to prevent herpes zoster and postherpetic neuralgia in older adults.

Authors:  James M Pellissier; Marc Brisson; Myron J Levin
Journal:  Vaccine       Date:  2007-10-17       Impact factor: 3.641

4.  Herpes zoster recurrences more frequent than previously reported.

Authors:  Barbara P Yawn; Peter C Wollan; Marge J Kurland; Jennifer L St Sauver; Patricia Saddier
Journal:  Mayo Clin Proc       Date:  2011-01-10       Impact factor: 7.616

5.  The patient record in epidemiology.

Authors:  L T Kurland; C A Molgaard
Journal:  Sci Am       Date:  1981-10       Impact factor: 2.142

6.  Cost-effectiveness of a vaccine to prevent herpes zoster and postherpetic neuralgia in older adults.

Authors:  John Hornberger; Katherine Robertus
Journal:  Ann Intern Med       Date:  2006-09-05       Impact factor: 25.391

7.  The accuracy of using a wound care specialty clinic database to study diabetic neuropathic foot ulcers.

Authors:  J Kantor; D J Margolis
Journal:  Wound Repair Regen       Date:  2000 May-Jun       Impact factor: 3.617

Review 8.  What does epidemiology tell us about risk factors for herpes zoster?

Authors:  Sara L Thomas; Andrew J Hall
Journal:  Lancet Infect Dis       Date:  2004-01       Impact factor: 25.071

9.  Health care utilization and cost burden of herpes zoster in a community population.

Authors:  Barbara P Yawn; Robbin F Itzler; Peter C Wollan; James M Pellissier; Lina S Sy; Patricia Saddier
Journal:  Mayo Clin Proc       Date:  2009-09       Impact factor: 7.616

10.  Herpes zoster ophthalmicus.

Authors:  Srinivasan Sanjay; Philemon Huang; Raghavan Lavanya
Journal:  Curr Treat Options Neurol       Date:  2011-02       Impact factor: 3.972

View more
  36 in total

1.  Post-shingles neuralgia by any definition is painful, but is it PHN?

Authors:  Barbara P Yawn
Journal:  Mayo Clin Proc       Date:  2011-12       Impact factor: 7.616

2.  Trends in Nationwide Herpes Zoster Emergency Department Utilization From 2006 to 2013.

Authors:  Erica D Dommasch; Cara J Joyce; Arash Mostaghimi
Journal:  JAMA Dermatol       Date:  2017-09-01       Impact factor: 10.282

3.  Increasing Incidence of Herpes Zoster Over a 60-year Period From a Population-based Study.

Authors:  Kosuke Kawai; Barbara P Yawn; Peter Wollan; Rafael Harpaz
Journal:  Clin Infect Dis       Date:  2016-05-08       Impact factor: 9.079

4.  Why patients visit their doctors: assessing the most prevalent conditions in a defined American population.

Authors:  Jennifer L St Sauver; David O Warner; Barbara P Yawn; Debra J Jacobson; Michaela E McGree; Joshua J Pankratz; L Joseph Melton; Véronique L Roger; Jon O Ebbert; Walter A Rocca
Journal:  Mayo Clin Proc       Date:  2013-01       Impact factor: 7.616

5.  Association between vaccination for herpes zoster and risk of herpes zoster infection among older patients with selected immune-mediated diseases.

Authors:  Jie Zhang; Fenglong Xie; Elizabeth Delzell; Lang Chen; Kevin L Winthrop; James D Lewis; Kenneth G Saag; John W Baddley; Jeffrey R Curtis
Journal:  JAMA       Date:  2012-07-04       Impact factor: 56.272

6.  Examination of links between herpes zoster incidence and childhood varicella vaccination.

Authors:  Craig M Hales; Rafael Harpaz; M Riduan Joesoef; Stephanie R Bialek
Journal:  Ann Intern Med       Date:  2013-12-03       Impact factor: 25.391

7.  Herpes Zoster as a Risk Factor for Incident Giant Cell Arteritis.

Authors:  Bryant R England; Ted R Mikuls; Fenglong Xie; Shuo Yang; Lang Chen; Jeffrey R Curtis
Journal:  Arthritis Rheumatol       Date:  2017-11-09       Impact factor: 10.995

8.  Ethnicity, Socioeconomic Status, and Health Disparities in a Mixed Rural-Urban US Community-Olmsted County, Minnesota.

Authors:  Chung-Il Wi; Jennifer L St Sauver; Debra J Jacobson; Richard S Pendegraft; Brian D Lahr; Euijung Ryu; Timothy J Beebe; Jeff A Sloan; Jennifer L Rand-Weaver; Elizabeth A Krusemark; YuBin Choi; Young J Juhn
Journal:  Mayo Clin Proc       Date:  2016-04-08       Impact factor: 7.616

9.  Risk of Stroke and Myocardial Infarction After Herpes Zoster in Older Adults in a US Community Population.

Authors:  Barbara P Yawn; Peter C Wollan; Maria A Nagel; Don Gilden
Journal:  Mayo Clin Proc       Date:  2015-12-15       Impact factor: 7.616

10.  Herpes zoster eye complications: rates and trends.

Authors:  Barbara P Yawn; Peter C Wollan; Jennifer L St Sauver; Linda C Butterfield
Journal:  Mayo Clin Proc       Date:  2013-05-09       Impact factor: 7.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.